{"count": 7, "results": [{"_id": "38251680", "pmid": 38251680, "title": "The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis).", "journal": "Curr Eye Res", "authors": ["Yagasaki R", "Morita A", "Mori A", "Sakamoto K", "Nakahara T"], "date": "2024-01-22T00:00:00Z", "doi": "10.1080/02713683.2024.2302865", "meta_date_publication": "2024 Jan 22", "meta_volume": "", "meta_issue": "", "meta_pages": "1-8", "score": 50249.418, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may exert beneficial effects against the progression of @<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@ocular diseases@@@ in which abnormal @DISEASE_Corneal_Neovascularization @DISEASE_MESH:D016510 @@@angiogenesis@@@ is associated with the pathogenesis.", "citations": {"NLM": "Yagasaki R, Morita A, Mori A, Sakamoto K, Nakahara T. The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis). Curr Eye Res. 2024 Jan 22;():1-8. PMID: 38251680", "BibTeX": "@article{38251680, title={The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis).}, author={Yagasaki R and Morita A and Mori A and Sakamoto K and Nakahara T}, journal={Curr Eye Res}, pages={1-8}}"}}, {"_id": "33047165", "pmid": 33047165, "title": "Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Nahar N", "Mohamed S", "Mustapha NM", "Lau S", "Ishak NIM", "Umran NS"], "date": "2021-03-01T00:00:00Z", "doi": "10.1007/s00210-020-01989-w", "meta_date_publication": "2021 Mar", "meta_volume": "394", "meta_issue": "3", "meta_pages": "457-467", "score": 50248.023, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuated @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@-associated histopathological @<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@eye deteriorations@@@, possibly partly by ameliorating vascular leakage, oxidative stress, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, and neovascularization, without affecting the fasting blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ levels or body weights in these @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@-induced @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Nahar N, Mohamed S, Mustapha NM, Lau S, Ishak NIM, Umran NS. Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model. Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):457-467. PMID: 33047165", "BibTeX": "@article{33047165, title={Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.}, author={Nahar N and Mohamed S and Mustapha NM and Lau S and Ishak NIM and Umran NS}, journal={Naunyn Schmiedebergs Arch Pharmacol}, volume={394}, number={3}, pages={457-467}}"}}, {"_id": "40190424", "pmid": 40190424, "title": "Metformin inhibits subretinal fibrosis by activating Klotho by miR-126-5p.", "journal": "Cytotechnology", "authors": ["Hua Z", "Zhu Q", "Yang J", "Zheng Y", "Yang W", "Li D", "Cui Y", "Shen L", "Rao L", "Zhang X", "Yuan L"], "date": "2025-06-01T00:00:00Z", "doi": "10.1007/s10616-025-00744-4", "meta_date_publication": "2025 Jun", "meta_volume": "77", "meta_issue": "3", "meta_pages": "84", "score": 50245.137, "text_hl": "@DISEASE_White_Dot_Syndromes @DISEASE_MESH:D000080363 @@@Subretinal fibrosis@@@ is a main cause of @DISEASE_Vision_Disorders @DISEASE_MESH:D014786 @@@visual loss@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@neovascular age-related macular degeneration@@@ (@DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@nAMD@@@), for whom there has been a lack of effective medication. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can improve @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and angiogenesis in @<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@eye diseases@@@. ", "citations": {"NLM": "Hua Z, Zhu Q, Yang J, Zheng Y, Yang W, Li D, Cui Y, Shen L, Rao L, Zhang X, Yuan L. Metformin inhibits subretinal fibrosis by activating Klotho by miR-126-5p. Cytotechnology. 2025 Jun;77(3):84. PMID: 40190424", "BibTeX": "@article{40190424, title={Metformin inhibits subretinal fibrosis by activating Klotho by miR-126-5p.}, author={Hua Z and Zhu Q and Yang J and Zheng Y and Yang W and Li D and Cui Y and Shen L and Rao L and Zhang X and Yuan L}, journal={Cytotechnology}, volume={77}, number={3}, pages={84}}"}}, {"_id": "35587864", "pmid": 35587864, "title": "Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.", "journal": "JAMA Ophthalmol", "authors": ["Vergroesen JE", "Thee EF", "Ahmadizar F", "van Duijn CM", "Stricker BH", "Kavousi M", "Klaver CCW", "Ramdas WD"], "date": "2022-07-01T00:00:00Z", "doi": "10.1001/jamaophthalmol.2022.1435", "meta_date_publication": "2022 Jul 1", "meta_volume": "140", "meta_issue": "7", "meta_pages": "674-681", "score": 50240.37, "text_hl": "@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was associated with a lower risk of @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@OAG@@@ (OR, 0.18; 95% CI, 0.08-0.41; P < .001). ", "citations": {"NLM": "Vergroesen JE, Thee EF, Ahmadizar F, van Duijn CM, Stricker BH, Kavousi M, Klaver CCW, Ramdas WD. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study. JAMA Ophthalmol. 2022 Jul 1;140(7):674-681. PMID: 35587864", "BibTeX": "@article{35587864, title={Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.}, author={Vergroesen JE and Thee EF and Ahmadizar F and van Duijn CM and Stricker BH and Kavousi M and Klaver CCW and Ramdas WD}, journal={JAMA Ophthalmol}, volume={140}, number={7}, pages={674-681}}"}}, {"_id": "19419339", "pmid": 19419339, "title": "A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.", "journal": "Curr Med Res Opin", "authors": ["St Charles M", "Minshall ME", "Pandya BJ", "Baran RW", "Tunis SL"], "date": "2009-06-01T00:00:00Z", "doi": "10.1185/03007990902870084", "meta_date_publication": "2009 Jun", "meta_volume": "25", "meta_issue": "6", "meta_pages": "1343-53", "score": 50051.914, "text_hl": "While costs were higher among @DISEASE_Ulcer @DISEASE_MESH:D014456 @@@renal, ulcer/@@@@DISEASE_Amputation_Congenital @DISEASE_MESH:C565682 @@@amputation/@@@@<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@neuropathy, and eye complications@@@ in the @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group, the cost savings for @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@CVD complications@@@ outweighed their economic impact. ", "citations": {"NLM": "St Charles M, Minshall ME, Pandya BJ, Baran RW, Tunis SL. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US. Curr Med Res Opin. 2009 Jun;25(6):1343-53. PMID: 19419339", "BibTeX": "@article{19419339, title={A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.}, author={St Charles M and Minshall ME and Pandya BJ and Baran RW and Tunis SL}, journal={Curr Med Res Opin}, volume={25}, number={6}, pages={1343-53}}"}}, {"_id": "30646124", "pmid": 30646124, "pmcid": "PMC6324274", "title": "Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin", "journal": "JAMA Netw Open", "authors": ["Vashisht R", "Jung K", "Schuler A", "Banda JM", "Park RW", "Jin S", "Li L", "Dudley JT", "Johnson KW", "Shervey MM", "Xu H", "Wu Y", "Natrajan K", "Hripcsak G", "Jin P", "Van Zandt M", "Reckard A", "Reich CG", "Weaver J", "Schuemie MJ", "Ryan PB", "Callahan A", "Shah NH"], "date": "2018-08-03T00:00:00Z", "doi": "10.1001/jamanetworkopen.2018.1755", "meta_date_publication": "2018 Aug 3", "meta_volume": "1", "meta_issue": "4", "meta_pages": "e181755", "score": 50050.6, "text_hl": "To identify which drug classes among @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, @GENE_DPP4 @GENE_1803 @@@dipeptidyl peptidase 4@@@ (@GENE_DPP4 @GENE_1803 @@@DPP-4@@@) inhibitors, and @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@ are associated with reduced hemoglobin A1c (HbA1c) levels and lower risk of @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney disorders@@@, and @<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@eye disorders@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a first-line therapy.", "citations": {"NLM": "Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, Li L, Dudley JT, Johnson KW, Shervey MM, Xu H, Wu Y, Natrajan K, Hripcsak G, Jin P, Van Zandt M, Reckard A, Reich CG, Weaver J, Schuemie MJ, Ryan PB, Callahan A, Shah NH. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin JAMA Netw Open. 2018 Aug 3;1(4):e181755. PMID: 30646124", "BibTeX": "@article{30646124, title={Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin}, author={Vashisht R and Jung K and Schuler A and Banda JM and Park RW and Jin S and Li L and Dudley JT and Johnson KW and Shervey MM and Xu H and Wu Y and Natrajan K and Hripcsak G and Jin P and Van Zandt M and Reckard A and Reich CG and Weaver J and Schuemie MJ and Ryan PB and Callahan A and Shah NH}, journal={JAMA Netw Open}, volume={1}, number={4}, pages={e181755}}"}}, {"_id": "30973575", "pmid": 30973575, "pmcid": "PMC6736343", "title": "The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration", "journal": "Invest Ophthalmol Vis Sci", "authors": ["Brown EE", "Ball JD", "Chen Z", "Khurshid GS", "Prosperi M", "Ash JD"], "date": "2019-04-01T00:00:00Z", "doi": "10.1167/iovs.18-26422", "meta_date_publication": "2019 Apr 1", "meta_volume": "60", "meta_issue": "5", "meta_pages": "1470-1477", "score": 50046.4, "text_hl": "Studies suggest that the commonly prescribed antidiabetic drug, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, is associated with decreased risk of several @<m>DISEASE_Eye_Diseases</m> @DISEASE_MESH:D005128 @@@ocular diseases@@@, but no work has investigated the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use on development of @DISEASE_Glycogen_Storage_Disease_Type_II @DISEASE_MESH:D006009 @@@AMD@@@. ", "citations": {"NLM": "Brown EE, Ball JD, Chen Z, Khurshid GS, Prosperi M, Ash JD. The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1470-1477. PMID: 30973575", "BibTeX": "@article{30973575, title={The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration}, author={Brown EE and Ball JD and Chen Z and Khurshid GS and Prosperi M and Ash JD}, journal={Invest Ophthalmol Vis Sci}, volume={60}, number={5}, pages={1470-1477}}"}}]}